Display options
Cite
Imajo K, Honda Y, Yoneda M, et al. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease. J Med Ultrason (2001). 2020;47(4):535-548doi: 10.1007/s10396-020-01059-x.
Imajo, K., Honda, Y., Yoneda, M., Saito, S., & Nakajima, A. (2020). Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease. Journal of medical ultrasonics (2001), 47(4), 535-548. https://doi.org/10.1007/s10396-020-01059-x
Imajo, Kento, et al. "Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease." Journal of medical ultrasonics (2001) vol. 47,4 (2020): 535-548. doi: https://doi.org/10.1007/s10396-020-01059-x
Imajo K, Honda Y, Yoneda M, Saito S, Nakajima A. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease. J Med Ultrason (2001). 2020 Oct;47(4):535-548. doi: 10.1007/s10396-020-01059-x. Epub 2020 Oct 27. PMID: 33108553.
Copy Download .nbib Format: NLM
Share it on

J Med Ultrason (2001). 2020 Oct;47(4):535-548. doi: 10.1007/s10396-020-01059-x. Epub 2020 Oct 27.

Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease.

Journal of medical ultrasonics (2001)

Kento Imajo, Yasushi Honda, Masato Yoneda, Satoru Saito, Atsushi Nakajima

Affiliations

  1. Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, 236-0004, Japan.
  2. Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, 236-0004, Japan. [email protected].

PMID: 33108553 DOI: 10.1007/s10396-020-01059-x

Abstract

The prevalence of nonalcoholic fatty liver disease (NAFLD) is expected to increase because of the current epidemics of obesity and diabetes, and NAFLD has become a major cause of chronic liver disease worldwide. Liver fibrosis is associated with poor long-term outcomes in patients with NAFLD. Additionally, increased mortality and liver-related complications are primarily seen in patients with nonalcoholic steatohepatitis (NASH); however, nonalcoholic fatty liver (NAFL) is believed to be benign and non-progressive. Therefore, distinguishing between NASH and NAFL is clinically important. Liver biopsy is the gold standard method for the staging of liver fibrosis and distinguishing between NASH and NAFL. Unfortunately, liver biopsy is an invasive and expensive procedure. Therefore, noninvasive methods, to replace biopsy, are urgently needed for the staging of liver fibrosis and diagnosing NASH. In this review, we discuss the recent studies on magnetic resonance imaging (MRI), including magnetic resonance elastography, proton density fat fraction measurement, and multiparametric MRI (mpMRI) that can be used in the assessment of NASH components such as liver fibrosis, steatosis, and liver injury including inflammation and ballooning.

Keywords: Corrected-T1; Magnetic resonance elastography; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Proton density fat fraction

MeSH terms

Publication Types